Acro Biomedical Co., Ltd.
ACBM
$0.0007
-$0.1043-99.33%
OTC PK
| 03/31/2025 | 09/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.85% | -- | 99.72% | 99.54% | 99.54% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.00% | -- | -99.97% | -99.98% | -99.98% |
| Change in Net Operating Assets | -325.00% | -- | -104.58% | 200.00% | 200.00% |
| Cash from Operations | -66.67% | -- | -141.07% | -18.87% | -18.87% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 67.67% | -- | -- | 4,750.00% | 4,750.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 67.67% | -- | -- | 4,750.00% | 4,750.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -- | 96.36% | 71.84% | 71.84% |